PURE Bioscience (PURE) announced its Q3 2025 financial results after market close.
The company reported revenue of $0.49 million, up from $0.44 million a year ago, representing an increase of approximately 11.4%.
Earnings showed a loss of $0.01, consistent with the loss recorded in the same period last year.
No estimates were provided for comparison in this report.
